Literature DB >> 9278551

Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1.

A Ericsson1, C Arias, P E Sawchenko.   

Abstract

We have provided evidence that the stimulatory effects of intravenous interleukin-1 (IL-1) on neurosecretory neurons in the paraventricular nucleus (PVH) that express corticotropin-releasing factor (CRF) depend specifically on the integrity of catecholaminergic projections originating in caudal medulla. Here we report on experiments designed to test alternative means by which circulating IL-1 might access medullary aminergic neurons, including mechanisms involving sensory components of the vagus, the area postrema, or perivascular cells bearing IL-1 receptors. Neither abdominal vagotomy nor area postrema lesions reliably altered Fos expression induced in the medulla or PVH in response to a moderately suprathreshold dose of IL-1beta. Cytokine-stimulated increases in CRF mRNA in the PVH were also unaffected by either ablation. By contrast, systemic administration of the cyclooxygenase inhibitor indomethacin resulted in parallel dose-related attenuations of IL-1 effects in hypothalamus and medulla. Microinjections of prostaglandin E2 (PGE2; >/=10 ng) in rostral ventrolateral medulla, the principal seat of IL-1-sensitive neurons that project to the PVH, provoked discrete patterns of cellular activation in hypothalamus and medulla that mimicked those seen in response to intravenous IL-1. We interpret these findings as supporting the hypothesis that paracrine effects of PGE2 released from perivascular cells in the medulla as a consequence of IL-1 stimulation and, acting through prostanoid receptors on or near local aminergic neurons that project to the PVH, contribute to the stimulatory effects of increased circulating IL-1 on neurons constituting the central limb of the hypothalamo-pituitary-adrenal axis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278551      PMCID: PMC6573255     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  54 in total

1.  Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain.

Authors:  C D Breder; W L Smith; A Raz; J Masferrer; K Seibert; P Needleman; C B Saper
Journal:  J Comp Neurol       Date:  1992-08-15       Impact factor: 3.215

2.  Estimation of nuclear population from microtome sections.

Authors:  M ABERCROMBIE
Journal:  Anat Rec       Date:  1946-02

3.  Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1.

Authors:  F Berkenbosch; J van Oers; A del Rey; F Tilders; H Besedovsky
Journal:  Science       Date:  1987-10-23       Impact factor: 47.728

4.  Localization of type I interleukin-1 receptor mRNA in the rat brain.

Authors:  K Yabuuchi; M Minami; S Katsumata; M Satoh
Journal:  Brain Res Mol Brain Res       Date:  1994-11

5.  Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones.

Authors:  H Besedovsky; A del Rey; E Sorkin; C A Dinarello
Journal:  Science       Date:  1986-08-08       Impact factor: 47.728

6.  A study on the role of circulating prostaglandin E2 in the adrenocorticotropin response to intravenous administration of interleukin-1beta in the rat.

Authors:  H Watanobe; R Nasushita; K Takebe
Journal:  Neuroendocrinology       Date:  1995-12       Impact factor: 4.914

7.  Influence of the paraventricular nucleus of the hypothalamus in the alteration of neuroendocrine functions induced by intermittent footshock or interleukin.

Authors:  S Rivest; C Rivier
Journal:  Endocrinology       Date:  1991-10       Impact factor: 4.736

8.  The pharmacokinetics, distribution and degradation of human recombinant interleukin 1 beta in normal rats.

Authors:  J Reimers; L D Wogensen; B Welinder; K R Hejnaes; S S Poulsen; P Nilsson; J Nerup
Journal:  Scand J Immunol       Date:  1991-11       Impact factor: 3.487

9.  Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype.

Authors:  A Honda; Y Sugimoto; T Namba; A Watabe; A Irie; M Negishi; S Narumiya; A Ichikawa
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

10.  The effects of recombinant human interleukin (IL)-1 alpha, IL-1 beta or IL-6 on hypothalamo-pituitary-adrenal axis activation.

Authors:  M S Harbuz; A Stephanou; N Sarlis; S L Lightman
Journal:  J Endocrinol       Date:  1992-06       Impact factor: 4.286

View more
  63 in total

Review 1.  Cognitive and behavioral consequences of impaired immunoregulation in aging.

Authors:  Angela W Corona; Ashley M Fenn; Jonathan P Godbout
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-20       Impact factor: 4.147

2.  Involvement of the arcuate nucleus of the hypothalamus in interleukin-1-induced anorexia.

Authors:  Teresa M Reyes; Paul E Sawchenko
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

Review 3.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

4.  Amygdaloid signature of peripheral immune activation by bacterial lipopolysaccharide or staphylococcal enterotoxin B.

Authors:  Geraldine Prager; Martin Hadamitzky; Andrea Engler; Raphael Doenlen; Timo Wirth; Gustavo Pacheco-López; Ute Krügel; Manfred Schedlowski; Harald Engler
Journal:  J Neuroimmune Pharmacol       Date:  2012-05-27       Impact factor: 4.147

5.  Ascending caudal medullary catecholamine pathways drive sickness-induced deficits in exploratory behavior: brain substrates for fatigue?

Authors:  Ronald P A Gaykema; Lisa E Goehler
Journal:  Brain Behav Immun       Date:  2010-11-12       Impact factor: 7.217

Review 6.  The overtraining syndrome in athletes: a stress-related disorder.

Authors:  A Angeli; M Minetto; A Dovio; P Paccotti
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

Review 7.  Review: microglia of the aged brain: primed to be activated and resistant to regulation.

Authors:  D M Norden; J P Godbout
Journal:  Neuropathol Appl Neurobiol       Date:  2013-02       Impact factor: 8.090

8.  Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes.

Authors:  Yoko Matsuoka; Tomoyuki Furuyashiki; Haruhiko Bito; Fumitaka Ushikubi; Yasuhiro Tanaka; Takuya Kobayashi; Seiji Muro; Noriko Satoh; Tetsuro Kayahara; Mikito Higashi; Akira Mizoguchi; Hitoshi Shichi; Yoshihiro Fukuda; Kazuwa Nakao; Shuh Narumiya
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

Review 9.  Attenuated hypothalamo-pituitary-adrenal axis responses to immune challenge during pregnancy: the neurosteroid opioid connection.

Authors:  Paula J Brunton; John A Russell
Journal:  J Physiol       Date:  2007-11-08       Impact factor: 5.182

10.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.